1 |
AZITHROMYCIN ORAL SUSPENSION IP |
AZITHROMYCIN DIHYDRATE |
IP |
|
|
|
EQ. TO AZITHROMYCIN ANHYDROUS |
|
200MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
2 |
PARACETAMOL ORAL SUSPENSION IP |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
PARACETAMOL |
IP |
250MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
3 |
MAGALDRATE AND SIMETHICONE ORAL SUSPENSION |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
MAGALDRATE (ANHYDROUS) |
IP |
400MG |
|
|
SIMETHICONE (ACTIVATED DIMETHICONE) |
IP |
40MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
4 |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, SODIUM CITRATE, CHLORPHENIRAMINE MALEATE, AMMONIUM CHLORIDE & MENTHOL ORAL SUSPENSION |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
PARACETAMOL |
IP |
250MG |
|
|
PHENYLEPHRINE HYDROCHLORIDE |
IP |
5MG |
|
|
CHLORPHENIRAMINE MALEATE |
IP |
2MG |
|
|
SODIUM CITRATE |
IP |
60MG |
|
|
AMMONIUM CHLORIDE |
IP |
120MG |
|
|
MENTHOL |
IP |
1MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
5 |
LACTULOSE ORAL SOLUTION USP |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
LACTULOSE CONCENTRATE EQ. TO LACTULOSE |
USP |
10GM |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
6 |
VITAMIN D3 ORAL SOLUTION |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
VITAMIN D3 |
IP |
60000 IU |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
7 |
TERBUTALINE SULPHATE, AMBROXOL HCL, & GUAIPHENESIN SYRUP |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
TERBUTALINE SULPHATE |
IP |
1.25MG |
|
|
AMBROXOL HYDROCHLORIDE |
IP |
15MG |
|
|
GUAIPHENESIN |
IP |
50MG |
|
|
MENTHOL |
IP |
1MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
8 |
DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL & CPM. SYRUP |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
DEXTROMETHORPHAN HYDROBROMIDE |
IP |
10MG |
|
|
PHENYLEPHRINE HYDROCHLORIDE |
IP |
5MG |
|
|
CHLORPHENIRAMINE MALEATE |
IP |
2MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
9 |
LEVOSALBUTAMOL SULPHATE, AMBROXOL HCL & GUAIPHENESIN SYRUP |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
LEVOSALBUTAMOL SULPHATE |
IP |
1MG |
|
|
AMBROXOL HYDROCHLORIDE |
IP |
30MG |
|
|
GUAIPHENESIN |
IP |
50MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
10 |
SUCRALFATE ORAL SUSPENSION |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
SUCRALFATE |
IP |
1000MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
11 |
POTASSIUM CITRATE & CITRIC ACID SYRUP |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
POTASSIUM CITRATE |
IP |
1100MG |
|
|
CITRIC ACID MONOHYDRATE |
IP |
334MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
12 |
ALUMINA, MAGNESIA, SIMETHICONE & OXETACAINE ORAL SUSPENSION |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
DRIED ALUMINIUM HYDROXIDE GEL EQ. TO ALLUMINIUM HYDROXIDE |
IP |
150MG |
|
|
MAGNESIUM TRISILICATE |
IP |
100MG |
|
|
MAGNESIUM HYDROXIDE |
IP |
25MG |
|
|
ACTIVATED DIMETHICONE |
IP |
10MG |
|
|
OXETACAINE |
|
Q.S |
|
|
IN A FLAVOURED SYRUPY BASE |
|
|
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
13 |
PEPSIN & FUNGAL DIASTASE SYRUP |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
PEPSIN (1:3000) |
IP |
7.5MG |
|
|
FUNGAL DIASTASE (1:1200) |
IP |
12.5MG |
|
|
SORBITOL |
IP |
250MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
14 |
TRICHOLINE CITRATE, SORBITOL & CYPROHEPTADINE HCL SYRUP |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
TRICHOLINE CITRATE |
IP |
375MG |
|
|
CYPROHEPTADINE HYDROCHLORIDE (ANHYDROUS) |
IP |
2MG |
|
|
SORBITOL SOLUTION 70% |
|
2GM |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|
15 |
MAGALDRATE, SODIUM ALGINATE & SIMETHICONE SUSPENSION |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
MAGALDRATE, |
IP |
500MG |
|
|
SODIUM ALGINATE |
IP |
100MG |
|
|
SIMETHICONE |
IP |
25MG |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
Levocetirizine Hydrochloride |
IP |
2.5mg |
16 |
Levocetirizine Hydrochloride & AMBROXOL |
AMBROXOL Hydrochloride |
IP |
30mg |
|
Hydrochloride Syrup |
IN A FLAVOURED SYRUPY BASE |
IP |
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
Zine Gluconate |
IP |
|
17 |
Zine Gluconate Oral Solution |
eq. to elemental zinc |
|
20mg |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
Ambroxol HCI,Guaiphenesin and |
Levosalbutamol SULPHATE |
IP |
|
17 |
Levosalbutamol Oral Solution |
eq. to Levosalbutamol |
|
1mg |
|
|
AMBROXOL HYDROCHLORIDE |
IP |
30mg |
|
|
GUAIPHENESIN |
IP |
50mg |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
10 |
Deflazacort ORAL SUSPENSION |
COMPOSITION:EACH 5ML CONTAINS: |
|
|
|
|
Deflazacort |
IP |
6mg |
|
|
IN A FLAVOURED SYRUPY BASE |
|
Q.S |
|
|
COLOUR: APPROVED COLOUR USED. |
|
|
|
|
|
|
|